New Zealand markets closed

NeoGenomics, Inc. (NEO)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
13.71-0.29 (-2.07%)
At close: 04:00PM EDT
13.91 +0.20 (+1.46%)
After hours: 07:34PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 1.75B
Enterprise value 1.97B
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)2.82
Price/book (mrq)1.90
Enterprise value/revenue 3.23
Enterprise value/EBITDA -27.92

Trading information

Stock price history

Beta (5Y monthly) 1.12
52-week change 3-17.36%
S&P500 52-week change 323.49%
52-week high 321.22
52-week low 311.03
50-day moving average 314.64
200-day moving average 315.23

Share statistics

Avg vol (3-month) 3732.93k
Avg vol (10-day) 3505.14k
Shares outstanding 5127.71M
Implied shares outstanding 6127.71M
Float 8126.01M
% held by insiders 11.28%
% held by institutions 1102.62%
Shares short (15 May 2024) 46.99M
Short ratio (15 May 2024) 48
Short % of float (15 May 2024) 47.61%
Short % of shares outstanding (15 May 2024) 45.47%
Shares short (prior month 15 Apr 2024) 47.64M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin -13.79%
Operating margin (ttm)-18.03%

Management effectiveness

Return on assets (ttm)-3.49%
Return on equity (ttm)-8.88%

Income statement

Revenue (ttm)610.66M
Revenue per share (ttm)4.86
Quarterly revenue growth (yoy)13.90%
Gross profit (ttm)N/A
EBITDA -20.51M
Net income avi to common (ttm)-84.23M
Diluted EPS (ttm)-0.66
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)384.83M
Total cash per share (mrq)3.01
Total debt (mrq)608.18M
Total debt/equity (mrq)65.86%
Current ratio (mrq)7.48
Book value per share (mrq)7.25

Cash flow statement

Operating cash flow (ttm)-15.18M
Levered free cash flow (ttm)-12.98M